CTLA4 and neoplasm: Whereas, once the tumor turns aggressive, tumor cells express immune checkpoint modulators [such as cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and programmed cell death 1 ligand 1 (PD-L1)] to suppress the immune response.